These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 32698755

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma.
    Ganipineni LP, Ucakar B, Joudiou N, Riva R, Jérôme C, Gallez B, Danhier F, Préat V.
    J Drug Target; 2019; 27(5-6):614-623. PubMed ID: 30633585
    [Abstract] [Full Text] [Related]

  • 23. Inhibitory potential of iRGD peptide-conjugated garcinol-loaded biodegradable nanoparticles in rat colorectal carcinoma.
    Paul B, Gaonkar RH, Dutta D, Dasi R, Mukherjee B, Ganguly S, Das SK.
    Biomater Adv; 2022 Mar; 134():112714. PubMed ID: 35581094
    [Abstract] [Full Text] [Related]

  • 24. Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel.
    Danhier F, Vroman B, Lecouturier N, Crokart N, Pourcelle V, Freichels H, Jérôme C, Marchand-Brynaert J, Feron O, Préat V.
    J Control Release; 2009 Dec 03; 140(2):166-73. PubMed ID: 19699245
    [Abstract] [Full Text] [Related]

  • 25. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F, Wang C, Lu Q, Zhao M, Ban FQ, Yu DH, Guan YY, Luan X, Liu YR, Chen HZ, Fang C.
    Biomaterials; 2013 Aug 03; 34(26):6163-74. PubMed ID: 23706689
    [Abstract] [Full Text] [Related]

  • 26. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z, Huang J, Xu Y, Zhang X, Teng Y, Huang C, Wu Y, Zhang X, Zhang H, Sun W.
    Oncotarget; 2015 Dec 08; 6(39):42150-68. PubMed ID: 26517524
    [Abstract] [Full Text] [Related]

  • 27. Paclitaxel/methotrexate co-loaded PLGA nanoparticles in glioblastoma treatment: Formulation development and in vitro antitumor activity evaluation.
    Madani F, Esnaashari SS, Bergonzi MC, Webster TJ, Younes HM, Khosravani M, Adabi M.
    Life Sci; 2020 Sep 01; 256():117943. PubMed ID: 32531377
    [Abstract] [Full Text] [Related]

  • 28. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
    Zheng K, Huang Z, Huang J, Liu X, Ban J, Huang X, Luo H, Chen Z, Xie Q, Chen Y, Lu Z.
    Drug Des Devel Ther; 2021 Sep 01; 15():2605-2618. PubMed ID: 34168432
    [Abstract] [Full Text] [Related]

  • 29. Alendronate/folic acid-decorated polymeric nanoparticles for hierarchically targetable chemotherapy against bone metastatic breast cancer.
    Chen SH, Liu TI, Chuang CL, Chen HH, Chiang WH, Chiu HC.
    J Mater Chem B; 2020 May 06; 8(17):3789-3800. PubMed ID: 32150202
    [Abstract] [Full Text] [Related]

  • 30. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
    Sharma N, Kumari RM, Gupta N, Syed A, Bahkali AH, Nimesh S.
    Molecules; 2020 Sep 16; 25(18):. PubMed ID: 32947799
    [Abstract] [Full Text] [Related]

  • 31. iRGD-paclitaxel conjugate nanoparticles for targeted paclitaxel delivery.
    Hu H, Wang B, Lai C, Xu X, Zhen Z, Zhou H, Xu D.
    Drug Dev Res; 2019 Dec 16; 80(8):1080-1088. PubMed ID: 31411346
    [Abstract] [Full Text] [Related]

  • 32. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H, Chen L, Gu J, Ren X, Wei Z, Luo J, Chen Y, Jiang X, Sha X, Fang X.
    Int J Pharm; 2010 Dec 15; 402(1-2):238-47. PubMed ID: 20934500
    [Abstract] [Full Text] [Related]

  • 33. Improved anti-glioblastoma efficacy by IL-13Rα2 mediated copolymer nanoparticles loaded with paclitaxel.
    Wang B, Lv L, Wang Z, Jiang Y, Lv W, Liu X, Wang Z, Zhao Y, Xin H, Xu Q.
    Sci Rep; 2015 Nov 16; 5():16589. PubMed ID: 26567528
    [Abstract] [Full Text] [Related]

  • 34. Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.
    Du R, Zhong T, Zhang WQ, Song P, Song WD, Zhao Y, Wang C, Tang YQ, Zhang X, Zhang Q.
    Int J Nanomedicine; 2014 Nov 16; 9():3091-105. PubMed ID: 25028548
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Controlled preparation and antitumor efficacy of vitamin E TPGS-functionalized PLGA nanoparticles for delivery of paclitaxel.
    Wang G, Yu B, Wu Y, Huang B, Yuan Y, Liu CS.
    Int J Pharm; 2013 Mar 25; 446(1-2):24-33. PubMed ID: 23402977
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Ultrasound-Mediated Microbubble Destruction (UMMD) Facilitates the Delivery of CA19-9 Targeted and Paclitaxel Loaded mPEG-PLGA-PLL Nanoparticles in Pancreatic Cancer.
    Xing L, Shi Q, Zheng K, Shen M, Ma J, Li F, Liu Y, Lin L, Tu W, Duan Y, Du L.
    Theranostics; 2016 Mar 25; 6(10):1573-87. PubMed ID: 27446491
    [Abstract] [Full Text] [Related]

  • 39. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer.
    Chen Y, Wang L, Luo S, Hu J, Huang X, Li PW, Zhang Y, Wu C, Tian BL.
    Drug Des Devel Ther; 2020 Mar 25; 14():2945-2957. PubMed ID: 32801636
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.